vs

Side-by-side financial comparison of Essex Property Trust (ESS) and Natera, Inc. (NTRA). Click either name above to swap in a different company.

Natera, Inc. is the larger business by last-quarter revenue ($665.5M vs $479.6M, roughly 1.4× Essex Property Trust). Essex Property Trust runs the higher net margin — 17.9% vs 7.1%, a 10.8% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs 5.5%). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs 6.0%).

Essex Property Trust is a publicly traded real estate investment trust that invests in apartments in California and in the Seattle metropolitan area.

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

ESS vs NTRA — Head-to-Head

Bigger by revenue
NTRA
NTRA
1.4× larger
NTRA
$665.5M
$479.6M
ESS
Growing faster (revenue YoY)
NTRA
NTRA
+34.3% gap
NTRA
39.8%
5.5%
ESS
Higher net margin
ESS
ESS
10.8% more per $
ESS
17.9%
7.1%
NTRA
Faster 2-yr revenue CAGR
NTRA
NTRA
Annualised
NTRA
34.5%
6.0%
ESS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ESS
ESS
NTRA
NTRA
Revenue
$479.6M
$665.5M
Net Profit
$85.7M
$47.3M
Gross Margin
70.0%
Operating Margin
31.7%
-3.4%
Net Margin
17.9%
7.1%
Revenue YoY
5.5%
39.8%
Net Profit YoY
-71.6%
187.9%
EPS (diluted)
$1.24
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESS
ESS
NTRA
NTRA
Q4 25
$479.6M
$665.5M
Q3 25
$473.3M
$592.2M
Q2 25
$469.8M
$546.6M
Q1 25
$464.6M
$501.8M
Q4 24
$454.5M
$476.1M
Q3 24
$450.7M
$439.8M
Q2 24
$442.4M
$413.4M
Q1 24
$426.9M
$367.7M
Net Profit
ESS
ESS
NTRA
NTRA
Q4 25
$85.7M
$47.3M
Q3 25
$172.7M
$-87.5M
Q2 25
$231.5M
$-100.9M
Q1 25
$212.8M
$-66.9M
Q4 24
$301.7M
$-53.8M
Q3 24
$125.5M
$-31.6M
Q2 24
$99.0M
$-37.5M
Q1 24
$285.1M
$-67.6M
Gross Margin
ESS
ESS
NTRA
NTRA
Q4 25
70.0%
Q3 25
69.2%
Q2 25
70.7%
Q1 25
69.6%
Q4 24
70.0%
Q3 24
69.5%
Q2 24
70.8%
Q1 24
69.7%
Operating Margin
ESS
ESS
NTRA
NTRA
Q4 25
31.7%
-3.4%
Q3 25
44.5%
-16.5%
Q2 25
59.5%
-20.2%
Q1 25
55.3%
-15.8%
Q4 24
67.0%
-13.6%
Q3 24
28.6%
-8.9%
Q2 24
31.1%
-10.6%
Q1 24
31.0%
-20.2%
Net Margin
ESS
ESS
NTRA
NTRA
Q4 25
17.9%
7.1%
Q3 25
36.5%
-14.8%
Q2 25
49.3%
-18.5%
Q1 25
45.8%
-13.3%
Q4 24
66.4%
-11.3%
Q3 24
27.8%
-7.2%
Q2 24
22.4%
-9.1%
Q1 24
66.8%
-18.4%
EPS (diluted)
ESS
ESS
NTRA
NTRA
Q4 25
$1.24
$0.36
Q3 25
$2.56
$-0.64
Q2 25
$3.44
$-0.74
Q1 25
$3.16
$-0.50
Q4 24
$4.00
$-0.41
Q3 24
$1.84
$-0.26
Q2 24
$1.45
$-0.30
Q1 24
$4.25
$-0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESS
ESS
NTRA
NTRA
Cash + ST InvestmentsLiquidity on hand
$76.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$5.5B
$1.7B
Total Assets
$13.2B
$2.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESS
ESS
NTRA
NTRA
Q4 25
$76.2M
Q3 25
$66.0M
$1.0M
Q2 25
$58.7M
$16.0M
Q1 25
$98.7M
$17.8M
Q4 24
$66.8M
$22.7M
Q3 24
$71.3M
$29.5M
Q2 24
$55.2M
$90.3M
Q1 24
$499.0M
$69.1M
Total Debt
ESS
ESS
NTRA
NTRA
Q4 25
Q3 25
$6.4B
Q2 25
$6.4B
Q1 25
$6.8B
Q4 24
Q3 24
$6.4B
Q2 24
$6.2B
Q1 24
$6.6B
Stockholders' Equity
ESS
ESS
NTRA
NTRA
Q4 25
$5.5B
$1.7B
Q3 25
$5.6B
$1.3B
Q2 25
$5.6B
$1.2B
Q1 25
$5.6B
$1.2B
Q4 24
$5.5B
$1.2B
Q3 24
$5.4B
$878.5M
Q2 24
$5.5B
$836.5M
Q1 24
$5.5B
$794.1M
Total Assets
ESS
ESS
NTRA
NTRA
Q4 25
$13.2B
$2.4B
Q3 25
$13.2B
$1.8B
Q2 25
$13.2B
$1.8B
Q1 25
$13.2B
$1.7B
Q4 24
$12.9B
$1.7B
Q3 24
$12.6B
$1.6B
Q2 24
$12.5B
$1.5B
Q1 24
$12.9B
$1.5B
Debt / Equity
ESS
ESS
NTRA
NTRA
Q4 25
Q3 25
1.15×
Q2 25
1.14×
Q1 25
1.22×
Q4 24
Q3 24
1.18×
Q2 24
1.13×
Q1 24
1.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESS
ESS
NTRA
NTRA
Operating Cash FlowLast quarter
$1.1B
$73.9M
Free Cash FlowOCF − Capex
$37.8M
FCF MarginFCF / Revenue
5.7%
Capex IntensityCapex / Revenue
5.4%
Cash ConversionOCF / Net Profit
12.53×
1.56×
TTM Free Cash FlowTrailing 4 quarters
$109.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESS
ESS
NTRA
NTRA
Q4 25
$1.1B
$73.9M
Q3 25
$342.6M
$59.4M
Q2 25
$216.1M
$37.6M
Q1 25
$281.5M
$44.5M
Q4 24
$1.1B
$52.9M
Q3 24
$316.2M
$51.8M
Q2 24
$218.9M
$4.0M
Q1 24
$314.9M
$27.0M
Free Cash Flow
ESS
ESS
NTRA
NTRA
Q4 25
$37.8M
Q3 25
$37.0M
Q2 25
$11.7M
Q1 25
$22.6M
Q4 24
$34.8M
Q3 24
$35.5M
Q2 24
$-7.7M
Q1 24
$6.7M
FCF Margin
ESS
ESS
NTRA
NTRA
Q4 25
5.7%
Q3 25
6.2%
Q2 25
2.1%
Q1 25
4.5%
Q4 24
7.3%
Q3 24
8.1%
Q2 24
-1.9%
Q1 24
1.8%
Capex Intensity
ESS
ESS
NTRA
NTRA
Q4 25
5.4%
Q3 25
3.8%
Q2 25
4.7%
Q1 25
4.3%
Q4 24
3.8%
Q3 24
3.7%
Q2 24
2.8%
Q1 24
5.5%
Cash Conversion
ESS
ESS
NTRA
NTRA
Q4 25
12.53×
1.56×
Q3 25
1.98×
Q2 25
0.93×
Q1 25
1.32×
Q4 24
3.54×
Q3 24
2.52×
Q2 24
2.21×
Q1 24
1.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons